Trivarx Ltd Cash Flow Conversion Efficiency
Trivarx Ltd cash flow conversion efficiency. Based on the latest financial reports, Trivarx Ltd (TRI) has a cash flow conversion efficiency ratio of -0.060x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-962.92K ≈ $-681.33K USD) by net assets (AU$15.97 Million ≈ $11.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Trivarx Ltd (2001–2026)
Cash flow conversion efficiency of Trivarx Ltd from 2001 to 2026. This chart illustrates how Trivarx Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Trivarx Ltd (TRI) share price today for real-time trading data and today's change.
Trivarx Ltd Cash Flow Conversion Ratio Explained
Trivarx Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Trivarx Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Trivarx Ltd ranked by their cash flow conversion efficiency. Also see TRI market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Godolphin Resources Ltd
AU:GRL
|
-0.172x |
|
Target Healthcare REIT Ltd
LSE:THRL
|
0.033x |
|
Osmosun SA
PA:ALWTR
|
138.991x |
|
Bermas SA
RO:BRM
|
N/A |
|
Avon Protection PLC
LSE:AVON
|
0.014x |
|
Bolt Biotherapeutics
NASDAQ:BOLT
|
-0.270x |
|
Kesla Oyj A
HE:KELAS
|
0.068x |
|
Asmallworld AG
SW:ASWN
|
0.480x |
Annual Cash Flow Conversion Efficiency for Trivarx Ltd (2001–2026)
The table below shows the annual cash flow conversion efficiency of Trivarx Ltd from 2001 to 2026. Review TRI FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-06-30 | AU$15.97 Million ≈ $11.30 Million |
AU$-1.51 Million ≈ $-1.07 Million |
-0.094x | -528.76% |
| 2025-06-30 | AU$12.65 Million ≈ $8.95 Million |
AU$-189.74K ≈ $-134.25K |
-0.015x | +90.22% |
| 2024-06-30 | AU$9.62 Million ≈ $6.81 Million |
AU$-1.48 Million ≈ $-1.04 Million |
-0.153x | -0.82% |
| 2023-06-30 | AU$6.13 Million ≈ $4.34 Million |
AU$-932.08K ≈ $-659.51K |
-0.152x | +91.20% |
| 2022-06-30 | AU$7.11 Million ≈ $5.03 Million |
AU$-12.28 Million ≈ $-8.69 Million |
-1.728x | -1567.31% |
| 2021-06-30 | AU$16.42 Million ≈ $11.62 Million |
AU$-1.70 Million ≈ $-1.20 Million |
-0.104x | +63.60% |
| 2020-06-30 | AU$12.61 Million ≈ $8.92 Million |
AU$-3.59 Million ≈ $-2.54 Million |
-0.285x | +64.24% |
| 2019-06-30 | AU$8.60 Million ≈ $6.09 Million |
AU$-6.85 Million ≈ $-4.85 Million |
-0.796x | +9.25% |
| 2018-06-30 | AU$13.99 Million ≈ $9.90 Million |
AU$-12.27 Million ≈ $-8.68 Million |
-0.877x | -115.28% |
| 2017-06-30 | AU$13.31 Million ≈ $9.42 Million |
AU$-5.42 Million ≈ $-3.84 Million |
-0.407x | -28.14% |
| 2016-06-30 | AU$8.49 Million ≈ $6.01 Million |
AU$-2.70 Million ≈ $-1.91 Million |
-0.318x | -91.22% |
| 2015-06-30 | AU$9.11 Million ≈ $6.45 Million |
AU$-1.52 Million ≈ $-1.07 Million |
-0.166x | +26.27% |
| 2014-06-30 | AU$2.71 Million ≈ $1.92 Million |
AU$-611.26K ≈ $-432.50K |
-0.226x | +51.35% |
| 2013-06-30 | AU$2.54 Million ≈ $1.80 Million |
AU$-1.18 Million ≈ $-832.63K |
-0.464x | +25.11% |
| 2012-06-30 | AU$2.44 Million ≈ $1.73 Million |
AU$-1.51 Million ≈ $-1.07 Million |
-0.619x | +80.13% |
| 2011-06-30 | AU$1.18 Million ≈ $833.18K |
AU$-3.67 Million ≈ $-2.60 Million |
-3.115x | -30.81% |
| 2010-06-30 | AU$1.10 Million ≈ $776.59K |
AU$-2.61 Million ≈ $-1.85 Million |
-2.381x | -185.48% |
| 2009-06-30 | AU$2.46 Million ≈ $1.74 Million |
AU$-2.05 Million ≈ $-1.45 Million |
-0.834x | -145.46% |
| 2008-06-30 | AU$5.68 Million ≈ $4.02 Million |
AU$-1.93 Million ≈ $-1.36 Million |
-0.340x | +35.54% |
| 2007-06-30 | AU$1.88 Million ≈ $1.33 Million |
AU$-992.15K ≈ $-702.01K |
-0.527x | -45.53% |
| 2006-06-30 | AU$2.26 Million ≈ $1.60 Million |
AU$-818.20K ≈ $-578.93K |
-0.362x | -61.21% |
| 2005-06-30 | AU$4.44 Million ≈ $3.14 Million |
AU$-997.01K ≈ $-705.45K |
-0.225x | +0.97% |
| 2004-06-30 | AU$4.86 Million ≈ $3.44 Million |
AU$-1.10 Million ≈ $-779.99K |
-0.227x | +64.67% |
| 2002-06-30 | AU$6.05 Million ≈ $4.28 Million |
AU$-3.89 Million ≈ $-2.75 Million |
-0.642x | -147.49% |
| 2001-06-30 | AU$6.05 Million ≈ $4.28 Million |
AU$-1.57 Million ≈ $-1.11 Million |
-0.260x | -- |
About Trivarx Ltd
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Med… Read more